These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 38027882)
21. Improved Aitongxiao prescription (I-ATXP) induces apoptosis, cell cycle arrest and blocks exosomes release in hepatocellular carcinoma (HCC) cells. Huang MB; Gao Z; Xia M; Zhao X; Fan X; Lin S; Zhang L; Huang L; Wei A; Zhou H; Wu JY; Roth WW; Bond VC; Leng J Int J Physiol Pathophysiol Pharmacol; 2022; 14(2):90-113. PubMed ID: 35619665 [TBL] [Abstract][Full Text] [Related]
22. The bioactive ingredients in Actinidia chinensis Planch. Inhibit liver cancer by inducing apoptosis. Hong Z; Lu Y; Ran C; Tang P; Huang J; Yang Y; Duan X; Wu H J Ethnopharmacol; 2021 Dec; 281():114553. PubMed ID: 34428524 [TBL] [Abstract][Full Text] [Related]
24. Anemoside B4 exerts anti-cancer effect by inducing apoptosis and autophagy through inhibiton of PI3K/Akt/mTOR pathway in hepatocellular carcinoma. Xue S; Zhou Y; Zhang J; Xiang Z; Liu Y; Miao T; Liu G; Liu B; Liu X; Shen L; Zhang Z; Li M; Miao Q Am J Transl Res; 2019; 11(4):2580-2589. PubMed ID: 31105864 [TBL] [Abstract][Full Text] [Related]
25. Crebanine induces ROS-dependent apoptosis in human hepatocellular carcinoma cells Tan J; Xiang Y; Xiong Y; Zhang Y; Qiao B; Zhang H Front Pharmacol; 2023; 14():1069093. PubMed ID: 36874025 [No Abstract] [Full Text] [Related]
26. Emodin inhibits invasion and migration of hepatocellular carcinoma cells via regulating autophagy-mediated degradation of snail and β-catenin. Qin B; Zeng Z; Xu J; Shangwen J; Ye ZJ; Wang S; Wu Y; Peng G; Wang Q; Gu W; Tang Y BMC Cancer; 2022 Jun; 22(1):671. PubMed ID: 35715752 [TBL] [Abstract][Full Text] [Related]
27. DAPT suppresses proliferation and migration of hepatocellular carcinoma by regulating the extracellular matrix and inhibiting the Hes1/PTEN/AKT/mTOR signaling pathway. Qiu K; Ma C; Lu L; Wang J; Chen B; Mao H; Wang Y; Wang H J Gastrointest Oncol; 2021 Jun; 12(3):1101-1116. PubMed ID: 34295560 [TBL] [Abstract][Full Text] [Related]
28. Xihuang pills induce apoptosis in hepatocellular carcinoma by suppressing phosphoinositide 3-kinase/protein kinase-B/mechanistic target of rapamycin pathway. Teng YJ; Deng Z; Ouyang ZG; Zhou Q; Mei S; Fan XX; Wu YR; Long HP; Fang LY; Yin DL; Zhang BY; Guo YM; Zhu WH; Huang Z; Zheng P; Ning DM; Tian XF World J Gastrointest Oncol; 2022 Apr; 14(4):872-886. PubMed ID: 35582102 [TBL] [Abstract][Full Text] [Related]
29. Comprehensive anti-tumor effect of Brusatol through inhibition of cell viability and promotion of apoptosis caused by autophagy via the PI3K/Akt/mTOR pathway in hepatocellular carcinoma. Ye R; Dai N; He Q; Guo P; Xiang Y; Zhang Q; Hong Z; Zhang Q Biomed Pharmacother; 2018 Sep; 105():962-973. PubMed ID: 30021391 [TBL] [Abstract][Full Text] [Related]
30. Knockdown of PKMYT1 is associated with autophagy inhibition and apoptosis induction and suppresses tumor progression in hepatocellular carcinoma. Wu F; Tu C; Zhang K; Che H; Lin Q; Li Z; Zhou Q; Tang B; Yang Y; Chen M; Shao C Biochem Biophys Res Commun; 2023 Jan; 640():173-182. PubMed ID: 36512849 [TBL] [Abstract][Full Text] [Related]
31. AKT/mTOR signaling pathway is involved in salvianolic acid B-induced autophagy and apoptosis in hepatocellular carcinoma cells. Gong L; Di C; Xia X; Wang J; Chen G; Shi J; Chen P; Xu H; Zhang W Int J Oncol; 2016 Dec; 49(6):2538-2548. PubMed ID: 27779641 [TBL] [Abstract][Full Text] [Related]
32. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway. Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274 [TBL] [Abstract][Full Text] [Related]
33. The mTOR inhibition in concurrence with ERK1/2 activation is involved in excessive autophagy induced by glycyrrhizin in hepatocellular carcinoma. Zhang X; Yang H; Yue S; He G; Qu S; Zhang Z; Ma B; Ding R; Peng W; Zhang H; Yang Z; Dou K; Tao K; Li X Cancer Med; 2017 Aug; 6(8):1941-1951. PubMed ID: 28675698 [TBL] [Abstract][Full Text] [Related]
34. Lobelia chinensis Lour inhibits the progression of hepatocellular carcinoma via the regulation of the PTEN/AKT signaling pathway in vivo and in vitro. Luo J; Chen QX; Li P; Yu H; Yu L; Lu JL; Yin HZ; Huang BJ; Zhang SJ J Ethnopharmacol; 2024 Jan; 318(Pt A):116886. PubMed ID: 37429502 [TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA ADAMTS9-AS1 exacerbates cell proliferation, migration, and invasion via triggering of the PI3K/AKT/mTOR pathway in hepatocellular carcinoma cells. Zhang Z; Li H; Hu Y; Wang F Am J Transl Res; 2020; 12(9):5696-5707. PubMed ID: 33042449 [TBL] [Abstract][Full Text] [Related]
36. Crocin induces autophagic apoptosis in hepatocellular carcinoma by inhibiting Akt/mTOR activity. Yao C; Liu BB; Qian XD; Li LQ; Cao HB; Guo QS; Zhou GF Onco Targets Ther; 2018; 11():2017-2028. PubMed ID: 29670377 [TBL] [Abstract][Full Text] [Related]
37. SNRPD1 inhibition suppresses the proliferation of hepatocellular carcinoma and promotes autophagy through the PI3K/AKT/mTOR/4EBP1 pathway. Wang H; Chen M; Yang C; Hu H; Jiang Y; Yang F; Lv L Arch Biochem Biophys; 2023 Jul; 743():109661. PubMed ID: 37268273 [TBL] [Abstract][Full Text] [Related]
38. Dual PI3K/mTOR inhibitor NVP-BEZ235-induced apoptosis of hepatocellular carcinoma cell lines is enhanced by inhibitors of autophagy. Chang Z; Shi G; Jin J; Guo H; Guo X; Luo F; Song Y; Jia X Int J Mol Med; 2013 Jun; 31(6):1449-56. PubMed ID: 23588698 [TBL] [Abstract][Full Text] [Related]
39. SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway. Zhang M; Liu S; Chua MS; Li H; Luo D; Wang S; Zhang S; Han B; Sun C Cell Death Dis; 2019 Aug; 10(8):612. PubMed ID: 31406106 [TBL] [Abstract][Full Text] [Related]
40. Natural product pectolinarigenin inhibits proliferation, induces apoptosis, and causes G2/M phase arrest of HCC via PI3K/AKT/mTOR/ERK signaling pathway. Wu T; Dong X; Yu D; Shen Z; Yu J; Yan S Onco Targets Ther; 2018; 11():8633-8642. PubMed ID: 30584322 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]